As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

In a report released yesterday, Cory Kasimov from Evercore ISI maintained a Hold rating on Moderna, with a price target of $32.00. The company’s shares closed yesterday at $27.64. Take advantage of ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

Currently trading with a volume of 3,803,131, the MRNA's price is down by -1.06%, now at $27.18. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

Dr. Peter Hotez, who leads the Center for Vaccine Development at Texas Children's Hospital, argues MRNA vaccines from Pfizer and Moderna proved highly effective.

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

The massive cuts by the Trump administration’s point man for destroying public health would dismantle a lifesaving technology ...

Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will ...